Arcadia Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Arcadia Biosciences

15/11/2021 23:26

* Arcadia Biosciences Inc  RKDA.OQ  reported a quarterly
adjusted loss of 10 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 29 cents per share.
* Revenue rose 656.7% to $2.38 million from a year ago; 
analysts expected $2.51 million. 
* Arcadia Biosciences Inc's reported EPS for the quarter was a
loss of 10 cents​.
* The mean earnings estimate of analysts had fallen by
about 10.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Arcadia Biosciences Inc shares had fallen by 4.8% this
quarter and lost 22.1% so far this year.
* The company reported a quarterly loss of $2.18 million.
* Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $5.75 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 11:26 p.m.
 ​All figures in US dollars unless otherwise stated